SOLUTIONES

Pagina prima>SOLUTIONES

Dorsum

PDRN, NAD+ et Centella Asiatica Curatio Cutis OEM: Ex Formula Activata ad Lineam Productorum Paratam ad Productionem

PDRN, NAD+ et Centella Asiatica Curatio Cutis OEM: Ex Formula Activata ad Lineam Productorum Paratam ad Productionem
PDRN & NAD+ Skincare OEM / ODM Solution

PDRN, NAD+ & Centella Skincare OEM

From Active Ingredient Brief to Stable, Market-Ready Product Line

INTE supports brands with active-ingredient formulation, product-line development, sample iteration, packaging coordination and production-ready technical documentation.

Turning Trending Actives into a Manufacturable Product Line

For skincare brands, choosing PDRN, NAD+ or Centella asiatica is only the first step. The more important questions are whether the formula is stable, whether the product can be reproduced consistently, whether the packaging is suitable and whether the complete line can move from sample approval to commercial production.

INTE adiuvat aequipes emptionis et productorum quaestionibus his per structuratum processum de evolutione OEM/ODM, non ut unumquodque productum tractetur ut formula isolata.

1,000+ Optiones formulae in bibliotheca evolutionis
40+ Personae technicae et qualitatis
12 Lineae productionis prudentes
7–10 Dies pro evolutione exemplaris post confirmationem principalium inputuum

Magnitudo bibliothecae formulae continue actualizatur. Disponibilitas relationum efficaciae, datum experimentorum et documentorum regulatoriorum est specifica pro singulis productis et confirmanda est durante recensione projectus.

Quid INTE solvit pro emptoribus B2B curae cutis

Projectum activi ingredientis felix debet connectere formulam, confectionem, experimenta et productionem. Munus INTE est adiuvare marcas ut per has fases progrediantur cum clarioribus inputibus technicis et minoribus iterationibus vitandis.

Planificatio stabilitatis formulae

  • Recensere compatibilitatem principalium activorum et ingredientium subsidiorum
  • Aestimare pH formulae, texturam, colorem et directionem fragrantiae
  • Identificare potestiales periculos antequam exemplar approbetur
  • Coordinare l’aggiustamento della formula secondo il feedback dell’acquirente

Sviluppo di prodotti per tutta la linea

  • Sviluppare diversi SKU intorno a un unico concetto di principio attivo
  • Coordinare consistenza di texture, colore e sensazioni tra i prodotti
  • Adattare i formati dei prodotti alle diverse routine dei consumatori
  • Supportare un portafoglio di prodotti scalabile anziché un singolo articolo isolato

Iterazione più rapida dei campioni

  • Confermare prima la funzione del prodotto e la direzione degli ingredienti
  • Programmare lo sviluppo dei campioni dopo l’approvazione degli input tecnici chiave
  • Raccogliere feedback strutturati dal team del marchio
  • Provide targeted adjustments for the next sample round

Production and Documentation Support

  • Provide product and manufacturing information for review
  • Coordinate packaging and filling requirements
  • Support product-specific testing and documentation
  • Prepare the project for commercial production review

Formula Development for PDRN, NAD+ and Centella Asiatica

Different active ingredients create different formulation considerations. Instead of adding trending ingredients to an existing base without review, the development process should consider the active system, supporting ingredients, product format, packaging and intended user experience together.

Ingredient selection is also supported by a focus on traceable cosmetic raw materials et la documentation technique spécifique au produit.

01

Compatibilitas Ingredientis Activi

Examiner la relation entre le principe actif principal, les ingrédients complémentaires, le système de conservation, la direction olfactive et le format du produit.

02

Contrôle de la texture et des sensations cutanées

Ajuster l’absorption, la facilité d’application, la viscosité, le toucher final, la couleur et la fragrance afin de correspondre au marché cible et au positionnement de la marque.

03

Cohérence entre échantillon et lot de production

Vérifier si l’échantillon approuvé peut être transposé dans un procédé de fabrication reproductible et dans un format d’emballage adapté.

Construire un portefeuille complet de soins cutanés autour d’un concept unique

De nombreuses marques ne souhaitent pas lancer un seul sérum. Elles ont besoin d’une matrice coordonnée de produits pouvant soutenir les ventes en ligne, les canaux de soins cutanés professionnels, la distribution en magasin ou une routine de soins multi-étapes.

Selon le concept du produit et le marché cible, un portefeuille contenant du PDRN, du NAD+ ou de la Centella asiatica peut inclure :

Nettoyage quotidien

Cleanser or cleansing mousse designed to prepare the skin for the subsequent routine.

Day and Night Care

Day cream and night cream with different texture, finish and routine positioning.

Tutela oculi

Eye cream or eye mask developed as a supporting product in the complete line.

Mask and Body Care

Facial masks, multi-effect masks or body lotion for expanding the product matrix.

Related development route: For brands beginning with a sensitive-skin positioning, see our Centella skincare sample development case for a related product-line approach.

Structured Development from Brief to Production

The following workflow is designed for brands that need clear handover points between product development, procurement, packaging and regulatory review.

Gradus 01

Brevis Descriptio Producti

Confirm the target consumer, product category, desired claims, active ingredients, texture, packaging direction and target quantity.

Stage 02

Recōnsiderātiō Formulārum

Review an existing formula, benchmark sample or new product concept and confirm the appropriate development route.

Gradus 03

Exemplaris Progressio

Develop samples after the product function and ingredient requirements have been confirmed.

Stage 04

Responsio et Iteratio

Collect feedback on texture, color, fragrance, absorption, packaging and positioning, then make targeted adjustments.

Stage 05

Testing and Documents

Coordinate applicable product testing and provide the technical information required for the buyer’s regulatory review.

Fase 06

Production Release

Konfirmi la formulon, la pakadon, la arton de la etikedo, la kvanton kaj la detalojn pri produktado antaŭ komerca produktado.

Tempolinio por provoj kaj produktado

La tempolinioj dependas de la komplekseco de la formulo, la haveblo de ingrediensoj, la postuloj pri pakado, la bezonoj pri testado kaj la rapido de la respondo de la aĉetanto.

Gradus operis Tipa tempolinio La tempolinio komenciĝas post
Exemplaris Progressio Circa 7–10 dies La funkcio de la produkto, la direkto pri ingrediensoj kaj la ĉefaj teknikaj postuloj estas konfirmitaj.
Iteracio de la formulo Ad Specificum Quodlibet Opus La respondo de la aĉetanto estas ricevita kaj la necesa direkto por aldonaj ŝanĝoj estas konfirmita.
Massa Productio Proksimume 28–45 tagoj Formula, packaging details, ingredients, and production approval are confirmed.
Packaging Sampling Ad Specificum Quodlibet Opus Packaging structure, decoration, and supplier requirements are confirmed.
Importans: Sample and mass-production timing normally excludes additional packaging sampling time. Special packaging may require a separate sampling cycle or packaging sample fee.

Product Information for Regulatory and Procurement Review

INTE provides factory-side and product-side technical information for the appointed Responsible Person, safety assessor, importer, or procurement team to review.

For brands preparing products for Europe and Great Britain, this technical package can be coordinated with a separate EU and UK market-entry preparation processu.

Factory-Side and Product-Side Information

  • Informātiō dē INCI et ingrediēntibus
  • Documenta dē māteriīs prīmīs, ubi praebentur
  • Specificationes producti
  • Informātiō dē COA applicābilis
  • Informatio de processu fabricationis
  • Packaging material information
  • Informacion microbiologica et de stabilitate, ubi disponibilis
  • Informacion de compatibilitate con imballagio, ubi applicabilis
  • Informationes ad probationem affirmationum, ubi applicabile

Responsabilitate regulatoria

  • Assessment final de securitate
  • Praeparatio de CPSR et PIF
  • Notificatio EU CPNP aut GB SCPN
  • Revision final de affirmationes
  • Approbatio de etiquetta specifica pro mercatu
  • Decision final de introitus in mercatu

INTE non agit ut Persona Responsabilis. Nos praebemus fundamentum technicum necessarium ad partes regulatorias nominatas ut suam revisionem compleant.

Dispositus pro Auctatione, Non Solum pro Approbatione de Exemplar

Pro teamas pro acquisitione, bonum exemplar est tantum unum momentum proiecti. Formula etiam debet esse idonea pro productione repetita, inspectione qualitatis, implendo, impachando et futura repletione.

Examinatio Formulae ad Processum

Examina utrum formula approbata possit adaptari ad processum productionis et implendi electum.

Packaging coordination

Confirma formatum impachandi, requisita implendi, informationem de decoratione et considerationes de compatibilitate.

Translatio Qualitatis

Concorda specificationes producti, requisita inspectionis et particularitates productionis antequam partus emittatur.

Quae Emptores Confirmare Debent Antequam Quotationem Postulent

Praebere sequentia informationes iuvat fabricantem ut proiectum accuratius aestimet et inutiles circulos quotationis et exemplorum minuat.

01

Directio Producti

Categoria producti, consumator ad quem destinatur, usus praefinitus, textura desiderata et positio producti.

02

Ingredientes activos

Ingredientia activa praeferranda, producta exemplaria, restrictiones ingredientium et directio affirmationis.

03

Emballatio

Praefertus typus, magnitudo, ornatus, formatum implendi et utrum iam electa sit conformatio.

04

Quantitas ad quam tenditur

Exspectata quantitas exemplorum, prima quantitas ordinis et exspectationes de futuris repletionibus.

05

Mercatus Objectivus

Europa, Magna Britannia, America Septentrionalis, Asia-Pacifica aut plures mercatus qui diversa itinera revisionis postulant.

06

Tempus inaugurationis

Desiderata dies exemplorum, terminus pro conformatione, dies productionis et tempus pro commerciali inauguratione.

Quaestiones Frequenter Rogatae

Num INTE potest lineam integram curativam cutis PDRN vel NAD+ elaborare?

Ita. Secundum brevem descriptionem producti, INTE potest adiuvare in elaboratione coordinati portfolii productorum, quae includunt lavamentum, cremam diurnam, cremam nocturnam, curam oculorum, fascias faciales et curam corporis.

Num ego possum formulam propriam aut exemplum comparativum praebere?

Ita. Marcae possunt praebere formulam iam existentem, exemplum comparativum aut conceptum producti. Aequipe technicum potest recensere informationes disponibiles et confirmare idoneum iter exemplorum.

Quanto tempore elaboratio exemplarium fit?

Sample development typically takes approximately 7–10 days after the product function, ingredient direction and key technical requirements have been confirmed. Additional formula iterations may require extra time.

How long does mass production take?

Mass production typically takes approximately 28–45 days after the formula, ingredients, packaging details and production approval have been confirmed. Packaging sampling time may be additional.

Does INTE handle CPNP registration?

INTE provides the product and technical information required for regulatory review. The appointed Responsible Person remains responsible for the final CPSR, PIF, CPNP or SCPN process and market-entry decision.

Are all formula options supported by human efficacy reports?

Efficacy documentation is product-specific. Third-party testing or additional efficacy studies can be discussed and arranged according to the product claims, target market and buyer requirements.

Develop Your PDRN, NAD+ or Centella Skincare Line

Mitte uns dein Produktbrief, den Zielmarkt, bevorzugte Wirkstoffe, die Verpackungsrichtung, die erwartete Bestellmenge und das geplante Markteinführungsdatum. Unser Team hilft dir dabei, den Formulentwicklungsansatz, den Musterplan und die Produktionsanforderungen zu bewerten.

Fordere eine Produktentwicklungsprüfung an
INTE bietet OEM/ODM-Fertigung und technische Unterstützung. Die Sicherheitsbewertung des Produkts, die regulatorische Anmeldung, die Genehmigung von Aussagen sowie die endgültigen Entscheidungen zum Markteintritt verbleiben bei der benannten Verantwortlichen Person und qualifizierten Fachleuten für Regulierungsfragen.
Praecedens

Centella Sensitive Skin Skincare Line | 7-Day Sample Development

OMNES

EU CPNP Notification Support: A Practical Compliance Workflow for Skincare Brands

Deinde
Producta commendata
WhatsApp WhatsApp Epistula electronica Epistula electronica Mobilis Mobilis SUMMUMSUMMUM